Trump has another tariff plan to reshore generic drug production. Will it work?

AI Summary

The Trump administration has proposed a new tariff plan aimed at reshoring generic drug production to the United States. The plan offers the pharmaceutical sector more transition time for its global supply chain adjustments.

The president’s most recent tariff proposal gives pharma more time to transition its global supply chain and reshore generic drug production.